Cue Biopharma, Inc. Annual Depreciation in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Cue Biopharma, Inc. quarterly/annual Depreciation history and growth rate from 2017 to 2023.
  • Cue Biopharma, Inc. Depreciation for the quarter ending September 30, 2024 was $100K, unchanged year-over-year.
  • Cue Biopharma, Inc. Depreciation for the twelve months ending September 30, 2024 was $467K, a 18.8% decline year-over-year.
  • Cue Biopharma, Inc. annual Depreciation for 2023 was $545K, a 34.4% decline from 2022.
  • Cue Biopharma, Inc. annual Depreciation for 2022 was $831K, a 8.59% decline from 2021.
  • Cue Biopharma, Inc. annual Depreciation for 2021 was $909K, a 16.5% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $545K -$286K -34.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $831K -$78.1K -8.59% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $909K +$129K +16.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
2020 $781K -$18.6K -2.33% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 $799K +$39.1K +5.15% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $760K +$340K +81.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $420K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.